Results 141 to 150 of about 43,811 (246)

Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis

open access: yesBioEssays, Volume 48, Issue 3, March 2026.
NLRP3, a cytosolic innate immune sensor, responds to diverse activators that perturb cellular homeostasis. These disturbances generate molecular scaffolds that, through binding partners such as nucleic acids, lipids, and proteins, recruit and concentrate NLRP3. Scaffold‐mediated NLRP3 clustering promotes NLRP3 inflammasome assembly.
Elvira Boršić‐Mlinarič   +1 more
wiley   +1 more source

Role of Kupffer cells in tolerance induction after liver transplantation. [PDF]

open access: yesFront Cell Dev Biol, 2023
Zheng W   +8 more
europepmc   +1 more source

Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective

open access: yesChronic Diseases and Translational Medicine, Volume 12, Issue 1, Page 39-48, March 2026.
ABSTRACT The liver is increasingly recognized as a major regulator of systemic cardio‐renal‐metabolic health. Evidence is mounting that sex‐chromosome dosage per se itself, independent of gonadal sex hormones, modulates hepatic physiology and liver disease risk.
Mohamad Jamalinia   +2 more
wiley   +1 more source

Axatilimab Immunogenicity and Clinical Relevance in Patients with Chronic Graft‐Versus‐Host Disease

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 791-801, March 2026.
Axatilimab, a monoclonal antibody targeting colony‐stimulating factor 1 (CSF‐1) receptor, is approved in the US for the treatment of chronic graft‐versus‐host disease (cGVHD) after failure of ≥2 lines of systemic therapy. In this study, the effects of antidrug antibody (ADA) status on the pharmacokinetics, pharmacodynamics, efficacy, and safety of ...
Yan‐ou Yang   +4 more
wiley   +1 more source

Mannose-Conjugated Cholesterol Containing Lipid Nanoparticles for Active Targeted mRNA Delivery to Liver Sinusoidal Endothelial and Kupffer Cells. [PDF]

open access: yesBioconjug Chem
Kim Y   +10 more
europepmc   +1 more source

Serum Inflammatory Markers and Dietary Inflammatory Index in Obese Individuals With Fatty Liver Disease: A Case–Control Study

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
Our findings underscore the role of inflammation in the pathophysiology of fatty liver disease among obese individuals. Elevated CRP levels highlight potential targets for intervention. ABSTRACT Background Fatty liver disease is common among obese individuals and is closely linked to chronic low‐grade inflammation.
Faezeh Tejareh   +2 more
wiley   +1 more source

Transcriptomic profiling of Kupffer cells exposed to <i>Clonorchis sinensis</i> extracellular vesicles: Unraveling the role of <i>CSF</i>3 in hepatic fibrosis. [PDF]

open access: yesFood Waterborne Parasitol
Lan Z   +10 more
europepmc   +1 more source

Multi‐Target Mechanisms of Whey Protein Against NAFLD: Integrating Bile Acid Metabolism, Gut Microbiota and Hepatic Inflammation

open access: yesFood Science &Nutrition, Volume 14, Issue 3, March 2026.
Whey protein (WP) alleviates high‐fat diet (HFD)‐induced nonalcoholic fatty liver disease (NAFLD) through a tripartite mechanism targeting the gut‐liver axis. (1) Gut Microbiota Modulation: WP restores intestinal flora homeostasis by enriching beneficial taxa (e.g., Lactobacillus) and increasing the production of short‐chain fatty acids (SCFAs).
Dongjin Xu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy